Related Experiment Video

Updated: Aug 17, 2026

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

[Relation between plasma levels of 8-methoxypsoralen and the phototoxic effect]

Dermatologica
|January 1, 1983
PubMed

Insights

This study investigated 8-methoxypsoralen (8-MOP) plasma levels and minimal phototoxic dose in six subjects. While an inverse relationship exists, current mathematical models do not perfectly predict phototoxicity from 8-MOP concentrations.

Area of Science:

  • Dermatology
  • Pharmacokinetics
  • Photobiology

Background:

  • 8-methoxypsoralen (8-MOP) is a photosensitizing agent used in photochemotherapy.
  • Understanding the relationship between 8-MOP plasma concentrations and phototoxic response is crucial for safe and effective treatment.
  • Variability in individual responses necessitates accurate predictive models.

Purpose of the Study:

  • To investigate the correlation between plasma concentrations of 8-MOP and the minimal phototoxic dose (MPD).
  • To evaluate the efficacy of existing mathematical models in predicting phototoxicity based on 8-MOP levels.

Main Methods:

  • Six subjects received 8-MOP at three different dose levels.
  • Plasma concentrations of 8-MOP were measured at 60, 120, and 180 minutes post-administration.
  • The minimal phototoxic dose (MPD) was determined for each subject.

Main Results:

  • An inverse correlation was observed between 8-MOP plasma concentrations and the determined MPD.
  • Despite the observed correlation, none of the eight mathematical expressions tested provided a perfect fit across all data points.
  • Individual variability in phototoxic response was evident.

Conclusions:

  • The relationship between 8-MOP plasma levels and phototoxicity is complex and not perfectly described by current mathematical models.
  • Further research is needed to develop more accurate predictive models for 8-MOP-induced phototoxicity.
  • Clinical management of photochemotherapy requires careful consideration of individual patient factors beyond simple pharmacokinetic measurements.

Related Concept Videos